INNOVATION IN CANCER TREATMENT
Normax offers our Educated Antigen Receptor Therapy (EARTh) Immunotherapies for personalized precision targeted cancer treatment.
EARTh Immunotherapies focuses on utilizing a patient’s own genetic information to develop targeted immunotherapies with mRNA technology.
INNOVATION IN CANCER TREATMENT
Normax offers our Educated Antigen Receptor Therapy (EARTh) Immunotherapies for personalized precision targeted cancer treatment.
EARTh Immunotherapies focuses on utilizing a patient’s own genetic information to develop targeted immunotherapies with mRNA technology.
The EARTh Immunotherapy Process
Patient Samples & Data
Tissue samples (healthy & cancerous) are collected from the patient with informed consent and undergo DNA sequencing.
AI-powered Analysis
Advanced AI tools process the DNA data to identify specific neoantigens (unique mutations) present inthe patient’s cancer cells.
mRNA Design & Production
The identified neoantigen sequences are used to design and print mRNA using technologies likeBioXP printer and DNA Script printer. This mRNA serves as the blueprint for personalized treatment.
Treatment Delivery
Autologous Cell Transfusion Delivery. Patient’s T cells are extracted and “educated” with the mRNA outside the bodybefore being reintroduced via transfusion.
GMP Lab Testing
Before administration, the effectiveness of the personalized mRNA treatment is rigorously tested in a controlled lab environment to ensure safety and efficacy.
How does EARTh immunotherapy work for our Patient?
Step 1
Patient Prescription By Patient’s Doctor (MD)
Step 2
Patient Tissue Samples: Healthy Cells & Cancer Cells
Step 3
Patient T-Cell Harvesting: By Your MD at The Hospital
Step 4
EARTh Production by NormaxBio For Patient
Step 5
EARTh Treatment Delivery to Patient’s MD
Step 6
Patient EARTh Treatment: By Patient’s MD The Hospital
Normax customers can procure treatment at our partner hospitals
Belgium
For many years, the Arsène Burny Cancer Institute of the CHU of Liège has strived to provide excellent care to people with cancer, from diagnosis of the disease to returning home, and this within the framework of a quality multidisciplinary approach centered on the person. Each patient is indeed followed by a team composed of experienced specialists from different fields of medicine and oncology .
United Kingdom
Nottingham University Hospitals are a leading Cancer Centre specialising in diagnosis, treatment, research and education. Nottingham University Hospitals provide services to the local population of Nottingham and we are the main tertiary specialist referral centre for hospitals in Lincoln, Sherwood Forest and Derby and the Nottingham Treatment Centre. We also receive referrals from Leicester and beyond for complex and rare cancers.
Normax Strategic Partners & Collaborators + Science, Technology & Service Providers + Leading Cancer Hospitals & Oncologists
